According to the research report,the global market for Next-Generation Immunology Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Next-Generation Immunology Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Next-Generation Immunology Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Cell Therapy segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Next-Generation Immunology Drugs include Pfizer Inc, Abbvie Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Amgen Inc., Novartis AG, Astellas Pharma Inc., Bristol-Myers Squibb Company and Merck & Co., Inc., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Next-Generation Immunology Drugs.
Report Highlights:

(1) Global Next-Generation Immunology Drugs market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Next-Generation Immunology Drugs market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Next-Generation Immunology Drugs market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Next-Generation Immunology Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Next-Generation Immunology Drugs segment by type and by application and regional segment by type and by application.

(6) Next-Generation Immunology Drugs industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Cell Therapy

Small Molecule Drug

Others

Market segment by application, can be divided into

Hospital

Clinic

Others

Market segment by players, this report covers

Pfizer Inc

Abbvie Inc.

Johnson and Johnson

F. Hoffmann-La Roche Ltd.

Amgen Inc.

Novartis AG

Astellas Pharma Inc.

Bristol-Myers Squibb Company

Merck & Co., Inc.

Eli Lilly and Company

1 Market Overview

1.1 Product Overview and Scope of Next-Generation Immunology Drugs

1.2 Global Next-Generation Immunology Drugs Market Size and Forecast

1.3 China Next-Generation Immunology Drugs Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Next-Generation Immunology Drugs Share in Global Market, 2018-2029

1.4.2 Next-Generation Immunology Drugs Market Size: China VS Global, 2018-2029

1.5 Next-Generation Immunology Drugs Market Dynamics

1.5.1 Next-Generation Immunology Drugs Market Drivers

1.5.2 Next-Generation Immunology Drugs Market Restraints

1.5.3 Next-Generation Immunology Drugs Industry Trends

1.5.4 Next-Generation Immunology Drugs Industry Policy

2 Global Competitive Situation by Company

2.1 Global Next-Generation Immunology Drugs Revenue by Company (2018-2023)

2.2 Global Next-Generation Immunology Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Next-Generation Immunology Drugs Concentration Ratio

2.4 Global Next-Generation Immunology Drugs Mergers & Acquisitions, Expansion Plans

2.5 Global Next-Generation Immunology Drugs Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Next-Generation Immunology Drugs Revenue by Company (2018-2023)

3.2 China Next-Generation Immunology Drugs Next-Generation Immunology Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Next-Generation Immunology Drugs, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Next-Generation Immunology Drugs Industry Chain

4.2 Next-Generation Immunology Drugs Upstream Analysis

4.3 Next-Generation Immunology Drugs Midstream Analysis

4.4 Next-Generation Immunology Drugs Downstream Analysis

5 Sights by Type

5.1 Next-Generation Immunology Drugs Classification

5.1.1 Cell Therapy

5.1.2 Small Molecule Drug

5.1.3 Others

5.2 By Type, Global Next-Generation Immunology Drugs Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Next-Generation Immunology Drugs Revenue, 2018-2029

6 Sights by Application

6.1 Next-Generation Immunology Drugs Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Others

6.2 By Application, Global Next-Generation Immunology Drugs Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Next-Generation Immunology Drugs Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Next-Generation Immunology Drugs Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Next-Generation Immunology Drugs Market Size, 2018-2029

7.3 North America

7.3.1 North America Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Next-Generation Immunology Drugs Market Size Market Share

7.4 Europe

7.4.1 Europe Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Next-Generation Immunology Drugs Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Next-Generation Immunology Drugs Market Size Market Share

7.6 South America

7.6.1 South America Next-Generation Immunology Drugs Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Next-Generation Immunology Drugs Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Next-Generation Immunology Drugs Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Next-Generation Immunology Drugs Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Next-Generation Immunology Drugs Market Size, 2018-2029

8.3.2 By Company, U.S. Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Next-Generation Immunology Drugs Market Size, 2018-2029

8.4.2 By Company, Europe Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Next-Generation Immunology Drugs Market Size, 2018-2029

8.5.2 By Company, China Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.5.3 By Type, China Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Next-Generation Immunology Drugs Market Size, 2018-2029

8.6.2 By Company, Japan Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Next-Generation Immunology Drugs Market Size, 2018-2029

8.7.2 By Company, South Korea Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Next-Generation Immunology Drugs Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Next-Generation Immunology Drugs Market Size, 2018-2029

8.9.2 By Company, India Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.9.3 By Type, India Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Next-Generation Immunology Drugs Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Pfizer Inc

9.1.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position

9.1.2 Pfizer Inc Company Profile and Main Business

9.1.3 Pfizer Inc Next-Generation Immunology Drugs Models, Specifications and Application

9.1.4 Pfizer Inc Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.1.5 Pfizer Inc Recent Developments

9.2 Abbvie Inc.

9.2.1 Abbvie Inc. Company Information, Head Office, Market Area and Industry Position

9.2.2 Abbvie Inc. Company Profile and Main Business

9.2.3 Abbvie Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.2.4 Abbvie Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.2.5 Abbvie Inc. Recent Developments

9.3 Johnson and Johnson

9.3.1 Johnson and Johnson Company Information, Head Office, Market Area and Industry Position

9.3.2 Johnson and Johnson Company Profile and Main Business

9.3.3 Johnson and Johnson Next-Generation Immunology Drugs Models, Specifications and Application

9.3.4 Johnson and Johnson Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.3.5 Johnson and Johnson Recent Developments

9.4 F. Hoffmann-La Roche Ltd.

9.4.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

9.4.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business

9.4.3 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Models, Specifications and Application

9.4.4 F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.4.5 F. Hoffmann-La Roche Ltd. Recent Developments

9.5 Amgen Inc.

9.5.1 Amgen Inc. Company Information, Head Office, Market Area and Industry Position

9.5.2 Amgen Inc. Company Profile and Main Business

9.5.3 Amgen Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.5.4 Amgen Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.5.5 Amgen Inc. Recent Developments

9.6 Novartis AG

9.6.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

9.6.2 Novartis AG Company Profile and Main Business

9.6.3 Novartis AG Next-Generation Immunology Drugs Models, Specifications and Application

9.6.4 Novartis AG Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.6.5 Novartis AG Recent Developments

9.7 Astellas Pharma Inc.

9.7.1 Astellas Pharma Inc. Company Information, Head Office, Market Area and Industry Position

9.7.2 Astellas Pharma Inc. Company Profile and Main Business

9.7.3 Astellas Pharma Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.7.4 Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.7.5 Astellas Pharma Inc. Recent Developments

9.8 Bristol-Myers Squibb Company

9.8.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

9.8.2 Bristol-Myers Squibb Company Company Profile and Main Business

9.8.3 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Models, Specifications and Application

9.8.4 Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.8.5 Bristol-Myers Squibb Company Recent Developments

9.9 Merck & Co., Inc.

9.9.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

9.9.2 Merck & Co., Inc. Company Profile and Main Business

9.9.3 Merck & Co., Inc. Next-Generation Immunology Drugs Models, Specifications and Application

9.9.4 Merck & Co., Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.9.5 Merck & Co., Inc. Recent Developments

9.10 Eli Lilly and Company

9.10.1 Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

9.10.2 Eli Lilly and Company Company Profile and Main Business

9.10.3 Eli Lilly and Company Next-Generation Immunology Drugs Models, Specifications and Application

9.10.4 Eli Lilly and Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

9.10.5 Eli Lilly and Company Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Next-Generation Immunology Drugs Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Next-Generation Immunology Drugs Market Restraints

Table 3. Next-Generation Immunology Drugs Market Trends

Table 4. Next-Generation Immunology Drugs Industry Policy

Table 5. Global Next-Generation Immunology Drugs Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Next-Generation Immunology Drugs Revenue Market Share by Company (2018-2023)

Table 7. Global Next-Generation Immunology Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Next-Generation Immunology Drugs Mergers & Acquisitions, Expansion Plans

Table 9. Global Next-Generation Immunology Drugs Manufacturers Product Type

Table 10. China Next-Generation Immunology Drugs Revenue by Company (2018-2023) & (US$ million)

Table 11. China Next-Generation Immunology Drugs Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Next-Generation Immunology Drugs Upstream (Raw Materials)

Table 13. Global Next-Generation Immunology Drugs Typical Customers

Table 14. Next-Generation Immunology Drugs Typical Distributors

Table 15. By Type, Global Next-Generation Immunology Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Next-Generation Immunology Drugs Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Next-Generation Immunology Drugs Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Next-Generation Immunology Drugs Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Next-Generation Immunology Drugs Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Next-Generation Immunology Drugs Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Next-Generation Immunology Drugs Revenue Market Share, 2018-2029

Table 22. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 23. Pfizer Inc Company Profile and Main Business

Table 24. Pfizer Inc Next-Generation Immunology Drugs Models, Specifications and Application

Table 25. Pfizer Inc Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 26. Pfizer Inc Recent Developments

Table 27. Abbvie Inc. Company Information, Head Office, Market Area and Industry Position

Table 28. Abbvie Inc. Company Profile and Main Business

Table 29. Abbvie Inc. Next-Generation Immunology Drugs Models, Specifications and Application

Table 30. Abbvie Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 31. Abbvie Inc. Recent Developments

Table 32. Johnson and Johnson Company Information, Head Office, Market Area and Industry Position

Table 33. Johnson and Johnson Company Profile and Main Business

Table 34. Johnson and Johnson Next-Generation Immunology Drugs Models, Specifications and Application

Table 35. Johnson and Johnson Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 36. Johnson and Johnson Recent Developments

Table 37. F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position

Table 38. F. Hoffmann-La Roche Ltd. Company Profile and Main Business

Table 39. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Models, Specifications and Application

Table 40. F. Hoffmann-La Roche Ltd. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 41. F. Hoffmann-La Roche Ltd. Recent Developments

Table 42. Amgen Inc. Company Information, Head Office, Market Area and Industry Position

Table 43. Amgen Inc. Company Profile and Main Business

Table 44. Amgen Inc. Next-Generation Immunology Drugs Models, Specifications and Application

Table 45. Amgen Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 46. Amgen Inc. Recent Developments

Table 47. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 48. Novartis AG Company Profile and Main Business

Table 49. Novartis AG Next-Generation Immunology Drugs Models, Specifications and Application

Table 50. Novartis AG Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 51. Novartis AG Recent Developments

Table 52. Astellas Pharma Inc. Company Information, Head Office, Market Area and Industry Position

Table 53. Astellas Pharma Inc. Company Profile and Main Business

Table 54. Astellas Pharma Inc. Next-Generation Immunology Drugs Models, Specifications and Application

Table 55. Astellas Pharma Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 56. Astellas Pharma Inc. Recent Developments

Table 57. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 58. Bristol-Myers Squibb Company Company Profile and Main Business

Table 59. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Models, Specifications and Application

Table 60. Bristol-Myers Squibb Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 61. Bristol-Myers Squibb Company Recent Developments

Table 62. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

Table 63. Merck & Co., Inc. Company Profile and Main Business

Table 64. Merck & Co., Inc. Next-Generation Immunology Drugs Models, Specifications and Application

Table 65. Merck & Co., Inc. Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 66. Merck & Co., Inc. Recent Developments

Table 67. Eli Lilly and Company Company Information, Head Office, Market Area and Industry Position

Table 68. Eli Lilly and Company Company Profile and Main Business

Table 69. Eli Lilly and Company Next-Generation Immunology Drugs Models, Specifications and Application

Table 70. Eli Lilly and Company Next-Generation Immunology Drugs Revenue and Gross Margin, 2018-2023

Table 71. Eli Lilly and Company Recent Developments

List of Figure

Figure 1. Next-Generation Immunology Drugs Picture

Figure 2. Global Next-Generation Immunology Drugs Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Next-Generation Immunology Drugs Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Next-Generation Immunology Drugs Market Share of Global

Figure 5. Global Next-Generation Immunology Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Next-Generation Immunology Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Next-Generation Immunology Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Next-Generation Immunology Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Next-Generation Immunology Drugs Industry Chain

Figure 10. Cell Therapy

Figure 11. Small Molecule Drug

Figure 12. Others

Figure 13. By Type, Global Next-Generation Immunology Drugs Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Next-Generation Immunology Drugs Revenue Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Clinic

Figure 17. Others

Figure 18. By Application, Global Next-Generation Immunology Drugs Revenue, 2018-2029, US$ Million

Figure 19. By Application, Global Next-Generation Immunology Drugs Revenue Market Share, 2018-2029

Figure 20. By Region, Global Next-Generation Immunology Drugs Revenue Market Share, 2018-2029

Figure 21. North America Next-Generation Immunology Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

Figure 23. Europe Next-Generation Immunology Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

Figure 25. Asia Pacific Next-Generation Immunology Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

Figure 27. South America Next-Generation Immunology Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Next-Generation Immunology Drugs Revenue Market Share, 2018-2023

Figure 29. Middle East & Africa Next-Generation Immunology Drugs Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 31. By Company, U.S. Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 32. By Type, U.S. Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 33. By Application, U.S. Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 34. Europe Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 35. By Company, Europe Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 36. By Type, Europe Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 37. By Application, Europe Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 38. China Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 39. By Company, China Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 40. By Type, China Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 41. By Application, China Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 42. Japan Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 43. By Company, Japan Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 44. By Type, Japan Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 45. By Application, Japan Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 46. South Korea Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 47. By Company, South Korea Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 48. By Type, South Korea Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 49. By Application, South Korea Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 50. Southeast Asia Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 51. By Company, Southeast Asia Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 52. By Type, Southeast Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 53. By Application, Southeast Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 54. India Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 55. By Company, India Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 56. By Type, India Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 57. By Application, India Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 58. Middle East & Asia Next-Generation Immunology Drugs Revenue, 2018-2029, (US$ Million)

Figure 59. By Company, Middle East & Asia Next-Generation Immunology Drugs Market Share, 2018-2023

Figure 60. By Type, Middle East & Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 61. By Application, Middle East & Asia Next-Generation Immunology Drugs Revenue Market Share, 2022 VS 2029

Figure 62. Research Methodology

Figure 63. Breakdown of Primary Interviews

Figure 64. Bottom-up Approaches

Figure 65. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)